长链非编码RNA H19介导系统性硬化症皮肤中STAT3依赖的角质形成细胞与成纤维细胞活化
本研究基于弥漫性系统性硬化症(SSc)患者(n=20)与健康对照(n=8)前臂皮肤活检及分离的真皮成纤维细胞,发现lncRNA H19在SSc皮肤和成纤维细胞中高表达,与促纤维化标志物中度相关。H19敲低可降低SSc成纤维细胞促纤维化基因表达和收缩能力,过表达则足以诱导健康成纤维细胞促纤维化表型;TGF-β、IL-6和IL-11通过STAT3激活上调H19表达,且H19敲低抑制SSc成纤维细胞共培养诱导的角质形成细胞STAT3和STAT1活化。
要点
- lncRNA H19在SSc皮肤和真皮成纤维细胞中高表达,与促纤维化标志物中度相关。
- H19敲低降低SSc成纤维细胞促纤维化基因表达和收缩能力,过表达诱导健康成纤维细胞促纤维化。
- TGF-β、IL-6和IL-11通过STAT3上调H19,H19敲低抑制角质形成细胞STAT3/STAT1活化。
核心结论
- lncRNA H19是SSc皮肤中STAT3诱导的成纤维细胞和角质形成细胞纤维化活化的关键介质,可能成为组织纤维化的治疗靶点。
研究设计与样本
- 获取弥漫性SSc患者(n=20)和健康对照(n=8)前臂皮肤活检并分离真皮成纤维细胞。
- 采用原位杂交检测皮肤H19表达,联合STAT3和Collagen1免疫组化。
- 通过逆转录病毒转导和小干扰RNA调控H19和STAT3表达,利用凝胶收缩和Transwell共培养进行功能研究。
主要发现
- SSc皮肤和分离的真皮成纤维细胞中H19表达高于健康对照,与已明确的促纤维化标志物呈中度相关。
- 敲低SSc成纤维细胞中H19可降低促纤维化基因表达和细胞收缩能力。
- H19过表达足以诱导健康对照成纤维细胞产生促纤维化表型。
- TGF-β、IL-6和IL-11分别使健康对照成纤维细胞H19表达增加2.2倍、1.4倍和3.5倍,通过激活STAT3实现。
- 与SSc成纤维细胞共培养诱导的角质形成细胞STAT3和STAT1活化可被H19敲低抑制。
关键数值与推荐
- SSc患者来源:弥漫性SSc(n=20)与健康对照(n=8)的前臂皮肤活检。
- TGF-β、IL-6和IL-11使健康对照成纤维细胞H19表达分别增加2.2倍、1.4倍和3.5倍。
临床怎么用
- H19可能作为SSc皮肤纤维化的潜在治疗靶点,但尚需进一步临床验证。
- H19表达与促纤维化标志物相关,或有助于评估SSc皮肤纤维化活动度。
局限性
- 样本量较小(SSc n=20,健康对照 n=8),结论需更大样本验证。
- 研究主要基于体外细胞实验,体内功能及治疗靶向性尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Dermal systemic sclerosis (SSc) fibroblasts and their exosomes can activate keratinocytes in SSc, with long noncoding RNA (lncRNA) H19 highlighted as the most up-regulated RNA in their cargo compared with healthy controls (HCs). The role of H19 in SSc pathogenesis has never been investigated. Here we determine H19's role in the profibrotic activation of dermal fibroblasts and in their crosstalk with keratinocytes. METHODS: Skin biopsies were obtained from the forearms of patients with diffuse SSc (n = 20) or HCs (n = 8), and dermal fibroblasts were explanted. In situ hybridization was used to determine H19 expression in the skin, paired with immunohistochemistry of STAT3 and Collagen1. H19 and STAT3 expression were modulated by retroviral transduction and small interfering RNA. Gel contraction and Transwell coculture were employed for functional studies. RESULTS: In SSc, high H19 expression in skin and explanted dermal fibroblasts compared with HCs showed moderate correlation to well-described profibrotic markers. Knockdown of H19 in SSc fibroblasts decreased profibrotic gene expression and cell contraction ability. H19 overexpression was sufficient to induce a profibrotic phenotype in HC fibroblasts. Mechanistically, transforming growth factor-β, interleukin-6, and interleukin-11 significantly increased H19 expression in HC fibroblasts (2.2-, 1.4-, and 3.5-fold, respectively) through activation of STAT3. Additionally, the STAT3 and STAT1 activation of keratinocytes induced by coculture with SSc fibroblasts was suppressed by H19 knockdown. CONCLUSION: This study shows that lncRNA H19 is a key mediator of STAT3-induced changes in fibrotic activation of fibroblast and keratinocytes in SSc skin and could be considered a promising therapeutic target in tissue fibrosis.
引用
- Caballero-Ruiz B, Wasson CW, Ross RL, et al. Long Noncoding RNA H19 Mediates STAT3-Dependent Activation of Keratinocytes and Fibroblasts in Systemic Sclerosis Skin. Arthritis Rheumatol. 2026. PMID: 41728987. doi:10.1002/art.70104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。